Register now for our annual BRCA Research Update Webinar: Looking Back At 2019 And Plans For The Future

Basser Center Executive Director Susan Domchek, MD, will present a webinar on recent advancements in BRCA-related research on Thursday, February 20 at
. Dr. Domchek will discuss recent clinical trials and scientific advancements, and breakthroughs in cancer treatment such as current FDA approvals.
Register now
The late Elizabeth Wurtzel, author and BRCA testing advocate

Remembering Elizabeth Wurtzel and Her Impact on BRCA Awareness

We were saddened to learn of the passing of Elizabeth Wurtzel, a gifted writer and dedicated hereditary cancer advocate, earlier this month. Elizabeth advocated for genetic testing for BRCA mutations as a potentially life-saving measure, which she writes about in the New York Times.

Cancer Today recently interviewed Susan Domchek, MD, about BRCA screening, who should get tested, and who is being left out under current guidelines. And for Medscape, Dr. Domchek discusses at-home genetic testing and whether or not patients who need these tests the most have access.
For the Basser blog, Basser genetic counselor Jessica Long, MS, LGCGC, writes about direct-to-consumer genetic testing and its potential benefits and potential risks.

In KvellerAbby Grayson also stresses the need for testing in the Ashkenazi community in a deeply personal piece that linked her own experience with Wurtzel's. "Every undiagnosed BRCA mutation is a failure of prevention."

The Reinterpretation of Genetic Tests Is Rare

In a letter-to-the-editor in the Wall Street Journal, also featured in the Basser blog, Basser physician Kara Maxwell, MD, PhD, and Basser Center Executive Director Susan Domchek, MD, responded to an article recently published about genetic testing, pointing out that reinterpretation of a patient’s genetic testing results is an incredibly rare case.

Penn Center for Genome Integrity: Hereditary Cancer and Beyond

On the Basser blog, Basser Director of Basic Science, Roger Greenberg, MD, PhD, introduces the new Penn Center for Genome Integrity, where he serves as Director. Dr. Greenberg explains the collaborative mission of the recently launched Center, discusses the importance of basic science in the field of hereditary cancer research, and describes ongoing research and plans for the future.

Basser Center Research Round Up

Olaparib Gains FDA Approval for Indication in Pancreatic Cancer
The PARP inhibitor olaparib has received FDA approval as a maintenance therapy for some BRCA-related pancreatic cancer patients, thanks to the results of the POLO trial, with participation from researchers at the Basser Center and Penn Medicine.

Penn Researchers Predict 10-Year Breast Cancer Recurrence with MRI Scans
According to a new study from Penn Medicine, MRI scans could predict breast cancer recurrence.

The Basser Center is proud to host and sponsor events throughout the country.
February 20, 2020
February 27, 2020
May 12, 2020
Save the Date for the 2020 Breakthroughs and Discoveries panel (Philadelphia, PA)

Basser Center
Facebook Twitter Instagram
basser.org | 215.662.2748
Manage your preferences | Opt out using TrueRemove®
Got this as a forward? Sign up to receive our future emails.
View this email online.
This email was sent to samantha.deighan@uphs.upenn.edu.
Continue receiving our emails, add us to your address book.